Clinical Gap Audit
Generated 2026-05-13T10:02:19Z. This page tracks the largest remaining clinical-coverage gaps. It is a maintainer audit, not clinical guidance.
| Gap | Current | Target | Status |
|---|---|---|---|
| Clinical sign-off | 15/1930 signoff-eligible entities reviewed (0.8%) | >=85% reviewed before public guideline-grade claims | blocked_on_reviewers |
| Solid tumor 2L+ coverage | 23/42 solid diseases have a 2L+ algorithm; 24/42 have a 2L+ indication | Every modeled solid disease has at least one advanced/relapsed-line algorithm and indication. | coverage_gap |
| Surgery/radiation detail | structured surgery entities: no; structured radiation entities: no; 424 indications mention surgery/radiation in text | Dedicated modality entities for surgery and radiation with dose/fraction/intent/timing fields. | schema_gap |
| Supportive-care depth | 135/370 regimens have mandatory supportive care (36.5%); 43 have monitoring; 327 have dose adjustments | Every active regimen has supportive care, monitoring, dose-adjustment, and patient-watchpoint coverage. | coverage_gap |
| Drug indication and off-label tracking | 812 drug-disease-indication pairs inferred from regimens; 0 carry explicit labeled/off-label status | Every drug-use pair has explicit regulatory-label status, NCCN/ESMO category, and source provenance. | schema_gap |
Clinical sign-off
Current: 15/1930 signoff-eligible entities reviewed (0.8%)
Blocker: Cannot be fixed by code; requires qualified Clinical Co-Lead review.
Next: Batch the largest STUB queues by entity type and assign reviewer owners.
Solid tumor 2L+ coverage
Current: 23/42 solid diseases have a 2L+ algorithm; 24/42 have a 2L+ indication
Blocker: Missing disease-by-disease 2L+ algorithm/indication authoring queue.
Next: Prioritize missing high-volume solid diseases, then rare solid diseases.
Surgery/radiation detail
Current: structured surgery entities: no; structured radiation entities: no; 424 indications mention surgery/radiation in text
Blocker: Current KB carries surgery/radiation mostly as prose inside indications.
Next: Add modality schemas first; migrate prose mentions after clinical review.
Supportive-care depth
Current: 135/370 regimens have mandatory supportive care (36.5%); 43 have monitoring; 327 have dose adjustments
Blocker: Supportive-care records exist, but regimen attachment is incomplete.
Next: Audit high-toxicity regimens first, then fill missing regimen attachments.
Drug indication and off-label tracking
Current: 812 drug-disease-indication pairs inferred from regimens; 0 carry explicit labeled/off-label status
Blocker: No first-class drug_indications entity directory/schema is present.
Next: Introduce a drug_indications entity, then backfill from existing indications/regimens.
/audits/clinical_gap_audit.json
and /audits/clinical_gap_audit.md.